Although these tumour types account collectively for the majority of RET fusion-positive cancers, RET fusions have also been observed in several other tumour types at a frequency of less than 1%, including cancers of the breast, colon, esophagus, ovary, prostate, stomach, pancreas, salivary gland, connective tissues, and iCCA. Here, RET is linked to breast cancer.